http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9709013-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
filingDate 1996-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d394062bfecbd26052d73028964b7801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f10fd59d93e59bc526a85db30a3e2b3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51122053edd4c5d8db2bc4aeb448ba38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ffcdbd1aae2e4f1b8c71d32ec4759db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92ee02dc23fd05260ec8de467ed322a8
publicationDate 1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9709013-A
titleOfInvention DOSAGE FORM INCLUDING OXYBUTININ.
abstract A composition comprising oxybutynin and a device comprising the same for oxybutynin therapy is described.
priorityDate 1995-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502831

Total number of triples: 34.